Arcadia Biosciences (RKDA) Tops Q2 EPS by 2c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
Go back to Arcadia Biosciences (RKDA) Tops Q2 EPS by 2c, Miss on Revenues
August 10, 2017 8:07 AM EDT
Arcadia Biosciences, Inc. (Nasdaq: RKDA) and Bioceres S.A. announced today their joint venture, Verdeca, received notification that the U.S. Food and Drug Administration (FDA) has completed its full review of the companys safety evaluation for HB4 soybeans. The FDAs notice to Verdeca allows products derived from HB4 soybeans to be used commercially in human food and animal feed. This is a major milestone in the development of commercial soybean seed products based on the HB4 stress tolerance trait.
The FDA uses its Biotechnology Notice process to review and assess safety... More
August 9, 2017 8:01 AM EDT
Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced today that Amy Yoder has joined its board of directors.
Yoder is president and CEO of Anuvia Plant Nutrients, a company that creates enhanced plant nutrition products from recycled organic waste sources. She is... More
